| Description |
1 online resource. |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Summary |
Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient. The book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles. The preparation, application, pros and cons of each nanomaterial class is reviewed, helping the reader understand the potential for each to tailor their own selections. Nanovaccines are also covered, along with a clinical evaluation and market analysis of nanomedicines for immunotherapy, offering an important clinical and commercial overview of this rapidly developing field. This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments. |
| Note |
Includes index. |
|
Print version record. |
| Subject |
Cancer -- Immunotherapy.
|
|
Nanomedicine.
|
|
Drug delivery systems.
|
|
Immunotherapy.
|
|
Nanomedicine |
|
Drug Delivery Systems |
|
Immunotherapy |
|
Cancer -- Immunothérapie.
|
|
Nanomédecine.
|
|
Systèmes d'administration de médicaments.
|
|
Immunothérapie.
|
| Added Author |
Kesharwani, Prashant, editor.
|
| Other Form: |
Print version: Nanomedicine in cancer immunotherapy. London, United Kingdom ; San Diego, CA : Academic Press, an imprint of Elsevier, [2024] 9780443187704 (OCoLC)1381294852 |
| ISBN |
9780443187704 |
|
0443187703 |
|
9780443187704 |
| Standard No. |
AU@ 000076053638 |
|
